BioPharm International Editors

CPhI released Part 3 of its annual industry report featuring three experts in the pharmaceutical industry.

The Apollo platform can be used throughout a product?s entire lifecycle.

The National Institutes of Health announces grants for the development of strategies for the utilization of biomedical data sets.

CSL Behring announced that it plans to invest $450 million to expand its Melbourne, Australia and Kankakee, Illinois facilities, which will increase production of albumin and plasma intermediates.

FDA granted Genentech priority review for its diabetic retinopathy treatment, Lucentis.

FDA outlines procedures for having a Critical Path Innovation Meeting with CDER.

FDA draft guidance outlines ways to minimize risk from acetaminophen-containing over-the-counter pediatric liquid drug products.

Celebrating the best of pharma and recognizing companies that turn inspiration into innovation.

FDA releases question and answer draft guidance on drug product tracing and licensing requirements.

Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.

NIH continues funding for tissue chips to be used in the development of therapeutics.

FDA report details risk mitigation projects.

USP expresses its support for a consensus-based global approach to the naming of biologics.

Regulations, product protection, and cost management are top concerns of supply chain decision makers.

Merck KGaA will expand the reach of its EMD Millipore division with the purchase of life-sciences company Sigma-Aldrich.

PCI's acquisition of Biotech Services International expands the packaging services provider's presence in Europe.

Texas A&M dedicates national pandemic influenza vaccine manufacturing facility.

GS1 publishes a healthcare industry guideline describing how to implement GS1 standards to support requirements of the 2013 US Drug Supply Chain Security Act.

GSK is found guilty of offering bribes to doctors and is fined $489 million.

GPhA throws its support behind a bill to prohibit companies from using REMS practices to deter competition.

Baxter announced that its new biopharmaceutical company will be named Baxalta when the company separates into two publicly traded companies in mid-2015.

Baxter International initiated a US voluntary recall of one lot of potassium chloride injection due to mislabeled shipping carton.

European Commission granted the first biosimilar insulin to receive regulatory approval in Europe.

Roche?s RoACTEMRA receives EU approval for use in patients with early rheumatoid arthritis.

ProBioGen, a biopharmaceutical drug manufacturer in Berlin, spends ?20 million to double its workforce.

PDA will publish a technical report on quality risk management aspects of drug shortages in early 2015.

Three-year agreement will support research on treatments for major brain disorders in Neuroscience Catalyst project.

The companies plan to develop and commercialize duvelisib (IPI-145).

DPT Laboratories acquired Media Pharmaceuticals' Lakewood, New Jersey facilities, providing space for aseptic processing suites and filling equipment.

The new China facility will be Merck KGaA's biopharmaceuticals division's second largest worldwide.